EP3297605
STAÐBUNDNAR LYFJAFRÆÐILEGAR EFNASAMSETNINGAR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.5.2016EP published:
4.5.2022EP application number:
16725243.6
EP translation filed:
25.4.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
18.5.2036Expiry date:
18.5.2026Next due date:
31.5.2026
Title in English:
TOPICAL PHARMACEUTICAL COMPOSITIONSLanguage of the patent:
English
Timeline
Today
19.5.2016EP application
25.4.2022Translation submitted
4.5.2022EP Publication
15.6.2022Registration published
18.5.2026Expires
Owner
Name:
Dermavant Sciences GmbHAddress:
Viaduktstrasse 8, 4051 Basel, CH
Inventor
Name:
BEDARD, MaryAddress:
North Carolina 27709, US
Name:
DOHERTY, Michael QuinnAddress:
Hillsborough, North Carolina 27278, US
Name:
LENN, Jon D.Address:
Durham, North Carolina 27703, US
Name:
SANTOS, Leandro L.Address:
North Carolina 27709, US
Name:
SONTI, Sujatha D.Address:
North Carolina 27709, US
Name:
THOMAS, Joey RogerAddress:
North Carolina 27709-3398, US
Name:
WHITEMAN, Justin E.Address:
Durham, North Carolina 27713, US
Name:
JAIN, PiyushAddress:
Chester Springs PA 19425, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562165097 PDate:
21.5.2015Country:
US
Number:
201662324450 PDate:
19.4.2016Country:
US
Classification
Categories:
A61K 9/00, A61K 9/107, A61K 9/113, A61K 31/05, A61P 17/00, A61P 17/06, A61P 17/08, A61P 17/10, A61P 29/00, A61P 31/10, A61P 37/08
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 7.6.2022
Expires: 18.5.2023
Payer: Patice ehf.
Number: 8
Paid: 22.4.2023
Expires: 18.5.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 19.4.2024
Expires: 18.5.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 13.5.2025
Expires: 18.5.2026
Payer: Árnason Faktor ehf.